Silvia Mancuso

Plain English
This study looked at how UV-B radiation affects quinoa plants when they are exposed to high salt levels. The researchers found that while salt alone can hurt the plants' growth and water use, adding UV-B radiation helped improve their photosynthesis and water management; specifically, it reduced the harmful effects of salt on the plants by about 36% to 47%. This is important because it shows that quinoa can better survive in salty conditions when exposed to UV-B, which could help in growing this crop in tougher environments. Who this helps: This helps farmers and agricultural scientists working to improve crop resilience in salty soils.

Plain English
Researchers from the Italian Society for Rheumatology created new treatment guidelines for patients who have both rheumatoid arthritis (RA) and interstitial lung disease (ILD), as there were no existing national or European guidelines. They reviewed existing research and consulted experts to outline recommendations for using existing drugs safely and effectively in this patient group, especially for those who do not respond to initial treatments. These guidelines aim to improve care for these patients and reduce the risks of serious health issues. Who this helps: Patients with rheumatoid arthritis and interstitial lung disease.

Plain English
This study looked at how biostimulants, natural substances that can boost plant growth, affect a specific type of Italian bean called Fagiolo di Sorana. Researchers found that using certain biostimulants increased the weight of the bean pods by 7% and improved the beans' nutritional quality by significantly raising their methionine content—by 200% and 400% compared to untreated beans. This is important because it helps address a common nutritional gap in beans, making them healthier for consumers. Who this helps: Patients looking for higher-nutrient food options, especially those with dietary restrictions.

Plain English
This study examined tiny particles called microvesicles found in the blood of patients with antiphospholipid syndrome (APS), a condition that can cause blood clots and pregnancy complications. Researchers found that the levels of these microvesicles were significantly higher in APS patients than in healthy individuals, with patients who had experienced miscarriages showing particularly high levels of a specific protein called cardiolipin. The findings suggest that these microvesicles may play a role in worsening the disease by activating cells that line blood vessels, which could lead to inflammation and clotting. Who this helps: This helps patients with antiphospholipid syndrome by providing insights into the disease's mechanisms and potential treatment strategies.

Plain English
This study looked at how an online exercise program could help middle-aged and older adults who have cognitive issues and mild mental health problems, such as anxiety or depression. Out of 55 participants, the number meeting recommended physical activity guidelines rose from only 3 (6%) to 24 (44%) after 12 weeks, and many saw significant reductions in their dementia risk and mental health symptoms. This matter because increasing physical activity can help reduce risks associated with dementia and improve overall mental health in this at-risk group. Who this helps: This helps middle-aged and older adults with cognitive concerns and mental health symptoms.

Plain English
This study looked at how well the Clinical Frailty Scale (CFS) can predict whether older patients with chronic lymphocytic leukemia (CLL) would stop treatment with a drug called zanubrutinib. Out of 326 patients aged 65 and older, 14.7% discontinued treatment within eight months, mainly due to side effects or disease progression. The results showed that patients with a CFS score greater than 3 had a much higher chance of stopping treatment after one year (29.2% discontinuation rate) compared to those with a score of 3 or less (8.8%). Who this helps: This helps doctors better identify which elderly patients with CLL may struggle with treatment.

Plain English
This study looked at how safe and effective two medications, zanubrutinib and ibrutinib, are for patients with chronic lymphocytic leukemia (CLL) in real-world settings. Researchers analyzed data from 934 patients and found that those taking zanubrutinib had lower rates of stopping treatment within a year (12.6% compared to 21.4% for ibrutinib) and better survival without needing new treatment or experiencing death (91.9% compared to 83.0%). This is important because it shows that zanubrutinib may provide better long-term disease control and fewer side effects, making it a potentially better treatment option for CLL. Who this helps: This research benefits CLL patients seeking more effective treatment options with fewer side effects.

Plain English
This study looked at how doctors treat lymphoma patients with vaccinations before starting cancer treatments. Researchers found that while there is awareness about the importance of vaccinations, doctors have different practices, with about 60% regularly discussing vaccination history with patients, but only 40% planning vaccinations consistently before treatments. This matters because getting vaccinated can reduce the infection risks these patients face, especially those undergoing specific therapies. Who this helps: This helps lymphoma patients by ensuring they receive timely vaccinations to protect their health.

Plain English
This study looked at how quickly patients with rheumatoid arthritis (RA) felt satisfied with their symptoms after starting treatment with a type of medication called Janus kinase inhibitors (JAK inhibitors). Researchers found that about 80% of the 113 patients achieved a satisfying symptom state within just 10 days. This is important because it indicates that JAK inhibitors can rapidly improve patients' health and quality of life, which is crucial for managing RA effectively. Who this helps: Patients with rheumatoid arthritis.

Plain English
This study looked at the prevalence of menopausal symptoms, specifically vasomotor symptoms (like hot flashes), in women aged 40 to 64 in the U.S. It found that out of over 7 million women, about 79 out of every 1,000 were diagnosed with these symptoms, with higher rates among non-Hispanic White women. The research also showed that Black, Asian, and Hispanic women were more likely to stop treatment for these symptoms compared to their White counterparts, and those with lower incomes faced an even higher risk of discontinuing treatment. Who this helps: This information helps women dealing with menopausal symptoms and healthcare providers understanding the disparities in diagnosis and treatment.

Plain English
This study looked at how safe and well-tolerated the medication fezolinetant is for women experiencing hot flashes and night sweats due to menopause. In a combined analysis of three studies involving nearly 3,200 women, it was found that 55.3% of those on placebo and about 63% to 65% of those taking fezolinetant reported side effects, with the most common being upper respiratory infections, headaches, and back pain. Importantly, serious side effects were low, and fezolinetant did not increase the risk of significant health issues related to the uterus. Who this helps: This research helps women dealing with menopausal symptoms and their healthcare providers.

Plain English
This study looked at how gender affects the risk of heart problems in patients with chronic myeloid leukaemia (CML) who are taking tyrosine kinase inhibitors (TKIs). Out of 148 patients, about 33% experienced a cardiovascular event, with a notably higher incidence of arterial and venous thrombosis in women compared to men. The findings highlight the importance of understanding these differences since the HFA-ICOS score proved to be more accurate in predicting heart issues in women, particularly those with diabetes, which significantly increased their risk. Who this helps: This research benefits patients and doctors by emphasizing the need for gender-specific care in managing heart risks for CML patients.

Plain English
This research reviewed how hot flashes and other menopause-related symptoms affect women's mental health across different reproductive stages. It found that between 1.4% and 58% of women experience depressive symptoms and 2.2% to 52% experience anxiety, with higher rates seen in women who have more severe hot flashes. This matters because it highlights that menopause symptoms significantly impact not just physical health but also mental well-being, showing a need for better support for women during this time. Who this helps: This helps women experiencing menopause and healthcare providers aiming to improve their care.

Plain English
This study looked at how effective and safe a medication called fezolinetant is for women aged 40 to 65 who can't use hormone therapy for menopausal hot flashes. Over 12 weeks, women taking 45 mg of fezolinetant experienced an average reduction of about 2.55 hot flashes per day compared to those on a placebo, and their sleep disturbances improved as well. Fezolinetant was generally well tolerated, with similar rates of side effects between those taking the medication and those on placebo. Who this helps: This research benefits women going through menopause who cannot use hormone therapy.

Plain English
This paper looks at how plants behave similarly to humans by using concepts from behavioral economics, particularly a theory called Two Minds that describes our intuitive and rational thinking processes. The researchers found that just like humans, plants exhibit behaviors that suggest they have two types of decision-making systems. For example, plants respond differently to various stimuli much like people do when faced with immediate versus long-term choices, indicating that they may have complex cognitive processes. Who this helps: This research helps scientists and ecologists better understand plant behavior and cognition.

Plain English
This study looked at how growing rice together with a water fern called Azolla affects rice plants' growth, grain yield, and quality. The researchers found that while Azolla helped rice plants grow better by increasing their size and improving some characteristics of their flowers, it also led to a decline in grain weight, keeping overall yields similar between rice grown alone and with Azolla. Specifically, they noted a 6% increase in the length of flower clusters and a 26% increase in branching, while zinc levels in the grains decreased by over 30%. Who this helps: This research benefits rice farmers looking for sustainable ways to improve yield and nutrient quality in their crops.

Plain English
This study examined how a specific antibody (anti-β2glycoprotein I) affects neutrophils and their ability to create structures called extracellular traps (NETs) that can activate cells lining blood vessels (endothelial cells). The researchers found that these NETs triggered a considerable increase in proteins associated with inflammation and blood clotting, specifically showing a 6-fold increase in tissue factor expression and a 4.2 and 2.3-fold increase in two other adhesion molecules. This finding is important because it helps clarify how these antibodies may contribute to complications in antiphospholipid syndrome, a condition that can lead to serious blood clotting issues. Who this helps: This research benefits patients with antiphospholipid syndrome and their healthcare providers by improving understanding of disease mechanisms.

Plain English
This study explored how to use the smell of coffee—specifically volatile organic compounds (VOCs)—to tell the difference between high-quality Arabica specialty coffees and others. Researchers examined 1,132 coffee samples and found that specialty coffees have a unique mix of aromas tied to their genetic background, with certain types like Bourbon and Typica releasing more pleasant smells. Understanding these aroma profiles not only helps consumers identify quality coffee but also protects them from fraud in the coffee industry. Who this helps: This helps coffee buyers, retailers, and consumers seeking high-quality Arabica coffee.

Plain English
This study examined patients with undifferentiated connective tissue disease (UCTD) to see how their condition evolves and how the new classification criteria for systemic lupus erythematosus (SLE) introduced in 2019 apply to them. Out of 201 UCTD patients, 13.4% already met the SLE criteria during their first visit, and by their last visit, an additional 7.8% qualified as having SLE. These findings show that many patients previously considered UCTD may actually have SLE, which is important for ensuring they receive the correct diagnosis and treatment. Who this helps: This helps patients with autoimmune diseases and their healthcare providers by improving diagnosis and treatment strategies.

Plain English
This study looked at the Total Metabolic Tumor Volume (TMTV) in patients with follicular lymphoma, a type of blood cancer. Researchers found that patients with a high TMTV—more than 180 mL—had a lower chance of surviving without cancer progression compared to those with a lower TMTV (59% vs. 74% over five years). This information is important because it helps doctors better predict how a patient’s cancer might behave and tailor treatment plans accordingly. Who this helps: This helps patients and doctors in making more informed treatment decisions for follicular lymphoma.

Plain English
This study looked at a treatment called copa-BR (copanlisib combined with rituximab and bendamustine) for patients with a type of cancer called diffuse large B-cell lymphoma who couldn't undergo certain other therapies. Out of 37 patients, only 24.3% responded to the treatment, and after 20 months, just 25.1% were still progression-free and 44.5% were still alive. The treatment also led to serious side effects in many patients, prompting researchers to stop the trial early because it was not effective enough or safe. Who this helps: This helps patients with relapsed lymphoma who have limited treatment options.

Plain English
This research paper looks at the history and differing views of abortion across cultures and religions. It found that while most major religions generally oppose abortion, the reasons and allowances for it vary widely. For example, while the Catholic Church strongly opposes it, some Muslim scholars permit it under certain circumstances, like within the first four months of pregnancy. Understanding the diverse perspectives on abortion helps promote dialogue rather than conflict. Who this helps: This benefits women facing unplanned pregnancies and the doctors advising them.

Plain English
This research paper looks at plastids, important structures within cells that help support life, especially through the process of photosynthesis found in plants and algae. The study highlights how plastids have evolved, their different functions, and how they connect with other cell parts, but there are still many mysteries about how they developed and work together. Understanding these processes is crucial because it can inform areas such as agriculture and renewable energy. Who this helps: This helps researchers and scientists working on food production and sustainable energy.

Plain English
This research reviewed existing studies to help the Italian Society of Rheumatology decide on the best treatments for lung disease related to rheumatoid arthritis (RA-ILD). The review included 69 studies with almost 8,000 patients and found that certain medications, like methotrexate, can reduce the risk of disease progression and death, while others like nintedanib show mixed results. These findings are important because they guide doctors in more effective treatment choices for patients suffering from this serious condition. Who this helps: Patients with rheumatoid arthritis-associated lung disease.

Plain English
This research looked at how a protein called HSP90 affects specific transporters in plants that help move plant hormones (auxins) within cells. The study found that HSP90 stabilizes certain transporters in the plant cell membrane, which is important for the plant's growth and development; for example, inhibiting HSP90 changed the stability of these transporters and affected how quickly they worked. Understanding this mechanism is important because it helps explain how plants can adapt their growth in response to their environment. Who this helps: This helps researchers studying plant growth and development.

Plain English
This study looked at how the plant Mimosa pudica reacts when it experiences mechanical stress, like being dropped. The researchers found that after multiple disturbances, the plant's ability to convert sunlight into energy decreased, and specific genes related to stress resistance were activated instead of those for making protective compounds. Understanding these responses can help scientists develop better methods for protecting crops from environmental stresses. Who this helps: This helps farmers and agricultural scientists working to improve plant resilience against stressors.

Plain English
This study looked at how different types of symptoms in systemic lupus erythematosus (SLE) patients influence their treatment choices, specifically between non-biologic and biologic immunosuppressants. They found that patients with kidney issues were four times more likely to start on mycophenolate, while those with joint problems were nearly five times more likely to begin treatment with methotrexate. Understanding these patterns can help doctors tailor treatments to fit patients' specific health profiles better. Who this helps: This helps patients with systemic lupus erythematosus and their doctors.

Plain English
This research looked at proteins linked to blood clots in patients with antiphospholipid syndrome (APS) compared to those with other types of blood clots. They found that 118 proteins were more active in those with APS, mostly related to how platelets work, while 319 proteins were identified in other types of clots, focusing more on wound healing and general blood clotting. Understanding these differences is important because it might lead to more specific treatments for APS that target platelet function. Who this helps: Patients with antiphospholipid syndrome.

Plain English
This study looked at how the plant Tetragonia tetragonioides, which can grow in salty soils, responded to different levels of salt and soil types in a greenhouse setting. It found that while the plant grew well at low and moderate salt levels, high salt (200 mmol/L) caused poor growth. However, at moderate salt, the plants became more efficient at using water and accumulated useful nutrients like copper, zinc, and manganese, which are important for human health. Who this helps: This research benefits farmers and food producers in salt-affected areas by offering a sustainable crop option.

Plain English
This study looked at the history and current state of abortion practices worldwide. It found that in 2022, about 970 million women could access abortion services, while roughly 700 million faced strict laws against it. The research highlights ongoing debates about abortion rights and the challenges women face in making choices about their reproductive health. Who this helps: This helps women seeking reproductive rights and access to safe abortion services.

Plain English
This study looked at how a 12-month remote monitoring program affects patients with obstructive sleep apnea who are using continuous positive airway pressure (CPAP) machines. The results showed that patients who received remote care used their CPAP machines for an average of 4.3 hours per night by the end of the year, an increase from 2.5 hours initially, while those receiving standard care did not see such significant improvement. Furthermore, 34.2% of patients in the remote care group improved their usage, compared to only 16.4% in the standard care group. Who this helps: This benefits patients with obstructive sleep apnea, particularly those struggling to adjust to CPAP treatment.

Plain English
This study looked at the ongoing debate over abortion rights and the growing global move towards legalizing abortion. It found that while there are strong opposing views—those who believe in protecting unborn life versus those advocating for women's reproductive choices—there is potential for common ground. Specifically, the research emphasizes the importance of reducing unwanted pregnancies through better access to contraception and family planning, which benefits everyone by minimizing the need for abortions. Who this helps: This helps women seeking reproductive health options and healthcare providers working to improve health outcomes.

Plain English
This study looked at four types of olives to understand how their physical features and chemical compounds can protect them from the olive fruit fly, a pest that causes significant damage. The researchers found that olives with thicker skins were less likely to be infested, and different types of olives released unique scents that might repel or attract the fly. This information is important for breeding more resilient olive varieties and improving pest management practices in olive farming. Who this helps: This helps olive farmers and agricultural scientists.

Plain English
This study examined the presence of specific antibodies in patients with a condition called antiphospholipid syndrome (APS), which causes blood clots and pregnancy complications. The researchers found that 34% of patients with thrombotic APS tested positive for these antibodies, and this positivity was linked to a higher risk of blood clots, especially in younger patients. Understanding these antibodies could lead to better monitoring and treatment for patients at risk of serious blood clotting events. Who this helps: Patients with antiphospholipid syndrome and their doctors.

Plain English
Researchers studied how nutrition affects survival in patients with myelofibrosis, a type of blood cancer. They found that patients with myelofibrosis tended to be malnourished, showing significant differences in body composition and metabolism compared to healthy individuals. Specifically, those with a lower phase angle—a measure of cell health—had worse survival rates, and those with larger spleens also did not survive as long. This is important because improving nutritional care could boost survival chances and quality of life for these patients. Who this helps: This helps patients with myelofibrosis and their healthcare providers.

Plain English
This study looked at whether giving a medication called Granulocyte Colony-Stimulating Factor (G-CSF) to couples experiencing repeated failures in getting pregnant through in vitro fertilization (IVF) could improve their chances of success. The researchers found that women who received G-CSF had a significantly higher chance of ongoing pregnancies (about 3.8 times more likely) and live births (about 5 times more likely), and a much lower chance of miscarriages (only 5.7% compared to those not treated). This is important because it suggests a way to boost the success rates of IVF for couples facing immunological issues that can hinder pregnancy. Who this helps: This helps couples with difficulty getting pregnant through IVF, especially those with specific immune system mismatches.

Plain English
Researchers surveyed 401 women experiencing moderate to severe menopause symptoms and 207 doctors treating these symptoms to understand their satisfaction with current treatments and their needs for future options. They found that women were moderately satisfied with hormonal treatments but had lower satisfaction with non-hormonal and over-the-counter options, scoring 62.8 to 67.3 for hormone therapy compared to 59.8 to 69.7 for non-hormonal therapy and 58.0 to 64.9 for OTC treatments. Doctors were more satisfied with hormone treatments (scores ranging from 73.4 to 75.6) but shared concerns about long-term safety, highlighting that 75% of both groups are open to new non-hormonal treatment options. Who this helps: This benefits women going through menopause and their healthcare providers.

Plain English
In this study, researchers looked at a group of 144 patients with a type of antiphospholipid syndrome (APS) that did not show positive results for standard antibody tests, known as "seronegative APS." They found that certain non-standard antibodies were present in these patients: 29.9% had aCarb-β2-GPI, 25.7% had aVim/CL, and 11.1% had aPS/PT. This is important because it suggests that testing for these non-standard antibodies could help diagnose patients who are currently overlooked. Who this helps: This helps patients with seronegative APS who may not be receiving appropriate care due to lack of positive test results.

Plain English
This study looked at the experiences of women aged 40-65 in the United States who suffer from hot flashes and night sweats due to menopause. Out of 196 women surveyed, 87% reported these symptoms, with 54% experiencing hot flashes during the day and 59% at night. Despite many women facing significant challenges, only 35% received treatment, often limited to hormone therapy for less than three years, showing a clear need for better support in managing these symptoms. Who this helps: This helps women going through menopause seeking better management of their symptoms.

Plain English
This study looked at five young and middle-aged patients who had unexplained strokes but tested negative for common types of antibodies usually linked to antiphospholipid syndrome (APS). All these patients showed signs of APS and tested positive for less common antibodies. The findings highlight the need for new testing methods to properly diagnose APS in patients who don’t fit the typical profiles, which could lead to better treatment outcomes. Who this helps: This research benefits patients who have unexplained strokes but may have APS that isn’t caught with standard tests.

Plain English
This study looked at the frequency and impact of menopause-related hot flashes and related symptoms in women who are either going through menopause or are 65 years and older in the U.S. It found that between 48.4% to 70.6% of perimenopausal women experience these symptoms, and they last an average of 2.6 years. For women aged 65 and older, 20.9% to 45.1% reported experiencing these symptoms, but very few reported them as severe. This research highlights the need for better ways to manage these symptoms and understand their overall effects on women’s health and quality of life. Who this helps: This helps women experiencing menopause, healthcare providers, and researchers.

Plain English
This study looked at new methods for creating complex structures that mimic blood vessels and nerve cells using different techniques, primarily bioprinting. Researchers found that while bioprinting can help place cells in precise patterns to better recreate these structures, challenges remain in making sure the cells stay alive and work properly together. Improving these methods could lead to breakthroughs in how we understand and treat conditions related to the brain and blood vessels. Who this helps: This helps patients with neurological disorders and vascular diseases, as well as researchers and doctors in the field of regenerative medicine.

Plain English
This study looked at how different factors affect the quality of life for patients with systemic lupus erythematosus (SLE), a chronic autoimmune disease. Researchers analyzed 237 patients and found that nearly half had anxiety (47.3%) and a significant number experienced depression (39.7%). They discovered that those with mood disorders, fibromyalgia, and chronic damage from SLE had a much lower quality of life, especially in areas like fatigue and feeling like a burden to others. Who this helps: This helps patients with SLE and their doctors by highlighting the importance of addressing mental health and chronic pain alongside the disease itself.

Plain English
This study looked at newly diagnosed multiple myeloma patients to understand how certain blood and lab test results relate to their survival. Among 190 patients analyzed over almost seven years, it found that 40% had died, with older age and specific blood measures, like higher red cell distribution width (RDW) and lower hemoglobin levels, linked to a higher risk of death. Understanding these factors is important because it can help doctors make better predictions about patient outcomes and tailor treatment accordingly. Who this helps: This helps patients and doctors in guiding treatment decisions for multiple myeloma.

Plain English
This study looked at a protein called Interleukin-32 (IL-32) in the kidneys of patients with lupus nephritis (LN), a severe form of lupus affecting the kidneys. Researchers found that IL-32 levels were higher in the kidney tissues of LN patients compared to those without kidney problems and that there was a link between higher IL-32 levels and longer disease duration (with a statistical significance of p=0.02). These findings suggest that IL-32 might play a role in the development of kidney issues in lupus patients, which is important for understanding how to better treat the condition. Who this helps: This helps patients with lupus nephritis and their doctors.